Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study

Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study

Background & objectives: Pioglitazone was suspended for manufacture and sale by the Indian drug regulator in June 2013 due to its association with urinary bladder carcinoma, which was revoked within a short period (July 2013). The present questionnaire-based nationwide study was conducted to ass...

Full description

Bibliographic Details
Main Authors: Aman Goyal, Harmanjit Singh, Vijay Kumar Sehgal, C R Jayanthi, Renuka Munshi, K Laxminarayana Bairy, Rakesh Kumar, Sandeep Kaushal, Ashish Kumar Kakkar, Sneha Ambwani, Chhaya Goyal, Goutameswar Mazumdar, Anjan Adhikari, Nina Das, Divya John Stephy, Pugazhenthan Thangaraju, D C Dhasmana, Shakil U Rehman, Amit Chakrabarti, Basavaraj Bhandare, Dinesh Kumar Badyal, Inderpal Kaur, K Chandrashekar, Jagjit Singh, Puneet Dhamija, Sudhir Chandra Sarangi, Yogendra Kumar Gupta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Medical Research
Subjects:
Compliance - drug safety - peroxisome proliferator-activated receptor-gamma agonist - pioglitazone - type 2 diabetes mellitus - urinary bladder carcinoma
Online Access:http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2017;volume=146;issue=4;spage=468;epage=475;aulast=Goyal

Internet

http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2017;volume=146;issue=4;spage=468;epage=475;aulast=Goyal

Similar Items